June Health review

June Health’s shop, peptide page and sermorelin product page each show a $259 starting monthly figure. PT-141 sits in Sexual Health; BPC-157, TB-500 and ipamorelin are not current peptide shop products. Its legal pages name June Health LLC and independent clinician networks, but terms still include template language. A product-page first-order refund promise conflicts with its shipping policy’s finality after shipment.

June Health trades as a direct-to-consumer telehealth storefront for weight loss, peptides, hormones, hair loss and ED, operated by June Health LLC from 1309 Coffeen Avenue, Suite 1200, Sheridan, Wyoming. Its terms describe it as a technology platform: prescribing is done by two independent medical groups, SamaritanMD and BeyondMD, and prescriptions are filled by 503A pharmacies arranged by those groups. The only purchasable item on its peptide shelf is sermorelin, listed at $259 ("Starting at $259/mo" on its product page). PT-141 is sold separately in the sexual-health range, from $179 a month or $159 as a nasal spray, and glutathione, NAD⁺ and methylene blue sit in the wellness range. The peptides page also names BPC-157, TB-500 and ipamorelin, but only in passages about how peptides work. The hormone line lists testosterone cypionate at $209 a month, enclomiphene capsules at $229, and estradiol and progesterone products. The weight-loss side lists compounded semaglutide and tirzepatide tablets from $187 and $249 a month, and combined formulations from $279 and $409.

Storefront-first: you pick a product, complete an intake, a clinician from one of the two named medical groups reviews it, and medication ships from the dispensing pharmacy in plain packaging. The product page states that your card is charged only if a clinician approves the prescription, which is the better sequence. Its sermorelin protocol describes nightly injections with a follow-up at six to twelve weeks, and the peptides page says protocols are adjusted using lab work, though no lab pricing is published. The terms, privacy policy, HIPAA notice and shipping policy are published, with Wyoming governing law, but the terms close with a line describing them as "a general template" that "should be reviewed by qualified counsel before publication". That suggests the document was published without that review. The address in Sheridan, Wyoming, is the only physical location given. No individual dispensing pharmacy is named — the terms say June Health holds no direct pharmacy contract — and no LegitScript seal appears. The domain was registered in May 2026, so there is little track record to weigh.

Sermorelin injection is shown from $259 per month on the current shop, peptide and product pages; the selected dose and first debit still require confirmation. Testosterone cypionate starts at $209/month and enclomiphene capsules at $229, while PT-141 injection starts at $179/month and nasal spray at $159. The selected first debit, quantity and any required lab charge were not established. The sermorelin page offers a 30-day first-order refund, while the shipping policy says shipped prescription medication cannot be returned and completed consultation fees are nonrefundable. Ask for written order-specific terms before paying.

Compounded; not FDA-approved. Prescription required only if a licensed provider finds it appropriate. The terms say prescriptions are filled by 503A compounding or dispensing pharmacies arranged by the prescribing group, and that the pharmacy's name will appear on your package, but no pharmacy is named before you buy — and compounded sterile products are not reviewed by the FDA for purity and potency the way approved drugs are. On the peptide line, only sermorelin is actually sold. It acts on the growth-hormone axis, a real and well-described mechanism with thin long-term human outcome data and no controlled trial supporting the body-composition or anti-aging claims on its page; the page's description of it as restoring "youthful GH levels safely" goes beyond the evidence. BPC-157, TB-500 and ipamorelin appear only in explanatory copy. BPC-157 and TB-500 have essentially no controlled human outcome trials; their tissue-repair reputation comes from animal studies and user reports. On the hormone line, testosterone therapy has a genuine evidence base together with real monitoring requirements and fertility suppression, and enclomiphene is offered alongside it. Individual results vary.